CALL US:022-6101 1710   sales@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 
News
 
Shardul Nautiyal, Mumbai November 17 , 2026
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has sought detailed inputs from pharmaceutical exporters on trade performance, market access barriers and export opportunities across eight South Asian markets, following a request from the Department of Commerce (DoC), Government of India. The objective is to identify industry-specific concerns and formulate measures to strengthen India's pharmaceutical trade with these countries.

The exercise is aimed at consolidating the pharmaceutical industry's priorities, export growth strategies and market access challenges for consideration during an upcoming review meeting with the DoC. The initiative follows a recent meeting involving the DoC, Pharmexcil, the Ministry of External Affairs (MEA) and Indian Missions abroad to review trade-related issues and identify measures to improve India's export engagement with neighbouring and other regional markets.

In a communication to its members, Pharmexcil has asked exporters to provide country-specific assessments covering Sri Lanka, Bangladesh, Nepal, Pakistan, Afghanistan, Iran, Maldives and Bhutan. The council is seeking actionable recommendations that could help address trade constraints, improve market access and create additional opportunities for Indian pharmaceutical manufacturers and exporters.

A key focus of the exercise is to identify strategies for increasing pharmaceutical exports through targeted trade facilitation measures suited to individual markets. Exporters have been asked to highlight opportunities for expanding their presence, identify specific policy or institutional interventions required and suggest measures that could improve the ease of doing business in these countries.

The council is also seeking information on pharmaceutical products with significant existing or potential demand in these markets. These include active pharmaceutical ingredients (APIs), finished formulations, vaccines and other pharmaceutical products that Indian manufacturers could supply to meet regional healthcare requirements. Such inputs are expected to help identify product-specific export opportunities and enable the government to align trade promotion initiatives with the requirements of individual importing countries.

Regulatory and non-regulatory market access barriers constitute another major component of the exercise. Pharmexcil has asked exporters to report difficulties arising from regulatory bottlenecks, delays in product registrations, non-tariff barriers, banking and payment restrictions, high import duties and other trade-related constraints affecting pharmaceutical exports.

Importantly, the council has requested members to accompany their assessment of these challenges with practical suggestions for resolving them. This is intended to help the government move beyond identifying trade impediments towards developing specific interventions through bilateral engagement, regulatory cooperation and trade facilitation mechanisms.

Pharmexcil is also seeking recommendations on the assistance required from the council, the DoC and Indian Missions in the respective countries. The proposed support could help address market-specific concerns, facilitate engagement with overseas regulatory authorities and government agencies, and improve coordination between Indian exporters and potential buyers in these markets.

According to Pharmexcil director general Raja Bhanu, the industry feedback will be important in preparing the council's representation to the Government of India. The objective is to ensure that the pharmaceutical sector's commercial interests, regulatory concerns and export expansion requirements are adequately reflected in the government's engagement with the identified countries.

The consolidated industry feedback is expected to provide the DoC with a clearer assessment of the opportunities and constraints facing Indian pharmaceutical exporters in these markets and help identify country-specific measures to strengthen pharmaceutical trade.

Share This Story

Leave a Reply
Your name (required)   Your email (required)
 
Website (required)
CommenT
Enter Code (Required)

 

 

 
INGREDIENT MART

RECENT NEWS

TOPICS
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2023 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Chrome (103.0) or Firefox (90.0)